Xperi Corporation (XPER) Tops Q2 EPS by 6c

Xperi Corporation (NASDAQ: XPER) reported Q2 EPS of ($0.09), $0.06 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $126.9 million versus the consensus estimate of $128.39 million.

GUIDANCE:

Xperi Corporation sees FY2023 revenue of $510-540 million, versus the consensus of $525.96 million.

For earnings history and earnings-related data on Xperi Corporation (XPER) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c